Understanding Islet Autoantibodies in Prediction of Type 1 Diabetes.
J Endocr Soc
; 8(1): bvad160, 2023 Dec 01.
Article
em En
| MEDLINE
| ID: mdl-38169963
ABSTRACT
As screening studies and preventive interventions for type 1 diabetes (T1D) advance rapidly, the utility of islet autoantibodies (IAbs) in T1D prediction comes with challenges for early and accurate disease progression prediction. Refining features of IAbs can provide more accurate risk assessment. The advances in islet autoantibodies assay techniques help to screen out islet autoantibodies with high efficiency and high disease specificity. Exploring new islet autoantibodies to neoepitopes/neoantigens remains a hot research field for improving prediction and disease pathogenesis. We will review the recent research progresses of islet autoantibodies to better understand the utility of islet autoantibodies in prediction of T1D.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
J Endocr Soc
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos